baber/WOPTO huggingface dataset:
Patent IE-34155-B1 (IE)
Title: Steroid estrogen sulfates and methods of preparing the same
IPC: A61K31/56
Filed: 1969-09-02
Abstract: 1,255,687. Derivatives of estradiol, 17α- estradiol and estriol. AMERICAN CYANAMID CO. 26 Aug., 1969 [4 March, 1969], No. 42524/69. Heading C2U. The invention comprises estradiol 17-sulphate triethylammonium salt (I), 17α-estradiol 17- sulphate triethylammonium salt (II), and estriol 16-sulphate triethylammonium salt (III). These compounds are prepared from estradiol, 17α- estradiol or estriol respectively by reaction with sulphur trioxide-triethylamine complex either in an anhydrous solvent at 10-100‹ C. or, for compounds I and III, or by fusion at 160- 250‹ C. Compounds and III are also prepared by heating estradiol 3-sulphate triethylammonium salt (IV) or estriol 3-sulphate triethylammonium salt (V) at 140-250‹ C.; or by hydrolysing the 3-acetates of compounds I and III by heating with triethylamine and an alcohol. Compound I is also prepared by fusion of estradiol with 3-sulphooxyestra- 1,3,5(10)-triene triethylammonium salt. The 3-acetates of compound I is prepared by treating estradiol with acetic anhydride and sulphur trioxide-triethylamine complex in either order or simultaneously. Compounds IV and V are prepared as described in Specification 1,255,686. Compounds I, II and III are stated to be estrogenic agents and may be made up with carriers into pharmaceutical compositions for oral and parenteral administration.
[GB1255687A]
Patent IE-50259-B1 (IE)
Title: Apparatus for handling palletized goods stacked in tiers
IPC: B65G57/00
Filed: 1980-06-19
Abstract: An apparatus for handling palletized goods stacked in tiers consists of a pivoted cradle having two substantially perpendicular supports for the goods, one of said supports normally constituting a horizontal loading plane and the other a vertical supporting plane, said planes being adapted alternatingly to support the goods due to the pivoting movement of the cradle. According to the invention the supporting plane is composed of a plurality of carriages which are movable towards and away from the loading plane in such a way that the various tiers are separable from each other when supported by the supporting plane formed of the carriages.
Patent IE-58564-B1 (IE)
Title: Tablet package and method of use
IPC: A61J1/03
Filed: 1986-06-30
Abstract: Packaging for a course of tablets comprises a base for a blister pack and a cover flap. Rub-off indicators are provided on the inner surface of the flap to permit indication of one of a range of atter- natives related to the course. The indicators may be colour keyed to particular doses of the course. A method of using such a pack is also disclosed.
Patent IE-38822-B1 (IE)
Title: Soluble aromatic copolyamides and threads thereof with a high modulus of elasticity and high tensile strength
IPC: C08G69/32
Filed: 1973-10-03
Abstract: The invention relates to copolyamides which have an extremely low water absorption capacity of 1 to 3.5 % but remarkably high tensile strengths of between 7 and 20 g/dtex and moduli of elasticity of between 500 and 11.000 kg.wt/mm2. The copolyamides comprise of from 50 to 95 mol.% of structural units of the general formula AND 5 TO 50 MOL% OF STRUCTURAL UNITS CONTAINING HYDANTOIN RINGS AND HAVING THE GENERAL FORMULA -HN-Y-Hy-Y'-Z-NH-OC-Ar-CO- wherein X, R1, R2, R3, R4, R5, R6, R7, Ar, Z, Y, Y' and Hy have the meaning described in the following specification.
[US3862088A]
Patent IE-41448-B1 (IE)
Title: Sedative method and composition
IPC: A61K45/08
Filed: 1975-08-11
Abstract: 1504302 Topical sedative compositions FISONS Ltd 12 Aug 1975 [23 Aug 1974] 37079/74 Heading A5B A method of sedating a non-human animal comprises applying to the skin of the animal in an amount sufficient to exert a sedative effect one or more sedative compounds. Compositions containing 2-Acetyl-10-(3-dimethylaminopropyl) phenothiazine and pharmaceutically acceptable salts thereof; 2-Chloro-10-(3- dimethylaminopropyl) phenothiazine and pharmaceutically acceptable salts thereof; 10- (3-dimethylaminopropyl) phenothiazine and pharmaceutically acceptable salts thereof; 10- (3-Dimethylamino-2-methylpropyl) phenothiazine and pharmaceutically acceptable salts thereof; 4'-fluoro-4-[4-(o-methoxyphenyl)-1-piperazinyl] butyrophenone and pharmaceutically acceptable salts thereof; 4'-fluoro-4-[4-(2- pyridyl)-1-piperazinyl] butyrophenone and 5, 6-dihydro-2-(2, 6-xylidino)-4H-1, 3 triazine and pharmaceutically acceptable salts thereof are also claimed.
Patent IE-60139-B1 (IE)
Title: Volume independent diagnostic device
IPC: G01N33/52
Filed: 1988-06-17
Abstract: A process and device for quantitative determination of analyte concentrations in liquid samples. The device includes one or more bibulous matrices constructed and arranged to essentially eliminate sample volume sensitivity from analyte determinations. In accordance with the present invention, the device includes one or more test reagent-treated bibulous matrices covered at least partially by an impermeable coating or film. A liquid sample is applied to the uncovered portion of the bibulous matrix such that the liquid sample is metered into the bibulous matrix by the impermeable coating or film. The sample chromatrographs through the bibulous matrix until the matrix is saturated with liquid. The process is essentially sample volume independent, providing more uniform and accurate quantitative analyte determinations.
Patent IE-54632-B1 (IE)
Title: Sorbitol-containing hard candy
IPC: A23G3/42
Filed: 1983-09-01
Abstract: A clear amorphous sugar-free hard candy prepared on a continuous basis from an aqueous sorbitol solution by heating such solution to a moisture-content level of less than about 5% by weight and then cooling the resulting mass to a temperature of from about 160 DEG F. to about 200 DEG F. before providing crystal nucleation sites sufficient to obtain a hard candy set time of no more than about 30 minutes in a metal mold.
Patent IE-50431-B1 (IE)
Title: A hip joint prosthesis
IPC: A61F2/36
Filed: 1980-10-10
Abstract: In patients with hypoplastic hip joints, hip joint prostheses with relatively thin and narrow shank blades must be used. For this reason, due to the torque effect of the force acting on the joint head, the danger exists that deformations of the shank blades may occur. This danger is counteracted in that the collar type projection forming the transition between the shank and the prosthesis neck extends in a direction parallel to the prosthesis neck, preferably in a prolongation of the lower edge of the prosthesis neck.
Patent IE-46157-B1 (IE)
Title: Improvements in and relating to the production of steel from iron carbide
IPC: C21B13/02
Filed: 1977-09-29
Abstract: Steel is obtd. directly from iron oxides by (a) converting the iron in the oxides to iron carbide and (b) converting the iron in the iron carbide to steel in a basic oxygen furnace. The heat for operation of the BOF is obtd. by oxidising the carbon of the iron carbide to carbon monoxide. Pref. the oxides are reduced and the iron converted to iron carbide in one step in a fluidised bed with a mixt. of hydrogen bearing gas and carbon contg. material, the amt. of H2 being >50 (esp. >60)% of the CO present. The iron carbide is added to the BOF and processed to steel without the addn. of external heat. Pref. the steps (a) and (b) are simultaneous and the process is auto-thermal. Steel is obtd. from iron oxide without using a blast furnace. Sources of heat for making the BOF process autothermal are obtd. in situ, i.e. sensible heat from the off-gases or the CO in the off-gases can be burned, or the CO can be reacted with the iron carbide of step (a) to raise the ratio of Fe2C to Fe3C in the charge so that sufficient carbon is available for combustion.
Patent IE-60671-B1 (IE)
Title: Monoclonal antiobodies to HIV and related peptides
IPC: C07K16/00
Filed: 1987-08-19
Abstract: Disclosed are monoclonal antibodies reactive with one or more neutralizing regions of HIV proteins, peptides or homologs of such neutralizing regions, and nucleic acid segments coding for said peptides. Neutralizing regions include portions of the env and gag genes from various HIV isolates. The monocional antibodies may be used to treat HIV infection or in diagnosis and the peptides may be used to elicit antibodies and to block HIV infection.
[DE3727703A1]
Patent IE-56600-B1 (IE)
Title: Azetidinyl sulfonic acid and analogs
IPC: C07D241/08
Filed: 1983-10-06
Abstract: Antibiotic activity is exhibited by beta -lactams having an  substituent in the 1-position and an acylamino substituent in the 3- position, R<5> and R<6> being hydrogen atoms at various defined substituents or R<5> and R<6> together completing a ring. The corresponding 3-amino compounds may be produced as intermediates. The compounds may be of the formula:-  or salts or esters thereof, R1 being hydrogen or acyl and R2, R3 and R4 being hydrogen atoms or substituents.
Patent IE-47762-B1 (IE)
Title: Improvements in and relating to the production of sleeves of sheet plastics material
IPC: B29C53/56
Filed: 1978-12-11
Abstract: In the packaging field certain types of packages are manufactured from pre-shaped, cylindrical casings made from a heat-shrinkable laminate. The casings are formed by winding a material sheet around a mandrel and subsequent sealing together of the overlapping ends of the sheet. However, because of the stiffness of the material the leading end of the sheet protrudes tangentially from the mandrel during the winding and prevents an accurate adaptation of the material sheet to the surface of the mandrel. According to the method and arrangement of this invention this disadvantage is avoided in that the leading end of the sheet is pre-heated on the side facing the mandrel to such a degree, that the shrinking is initialled. The shrinking of one side only results in that the leading end of the material sheet is given a curved shape with a radius that coincides with the radius of the mandrel, and consequently the leading end is no longer an obstacle to the winding.
Patent IE-64060-B1 (IE)
Title: Improvements in or relating to cutting elements for rotary drill bits
Inventor: NEWTON THOMAS ALEXANDER JR
IPC: E21B10/56
Filed: 1990-08-07
Abstract: A preform cutting element or rotary drill bit for use in drilling or coring holes in subsurface formations includes a cutting table (12, 13) of superhard material such as polycrystalline diamond. The rear face of the cutting table is bonded to a substrate (11) of less hard material, such as cemented tungsten carbide. A front portion (12) of the cutting table comprises a form of superhard material which is less wear-resistant than the superhard material forming the remainder (13) of the cutting table. The provision of the less wear-resistant superhard material at the front cutting faces reduces the tendency of the cutting table to spall.
Patent IE-60571-B1 (IE)
Title: Process for the preparation of cefodizime
IPC: C07D501/36
Filed: 1986-12-02
Abstract: A process for the preparation of cefodizime of the formula +TR wherein (a) a compound of the formula II (ATS) wherein R1 represents hydrogen or an aminoprotective group and A represents a hydrogen atom or one equivalent of an alkali metal or alkaline earth metal, of ammonium or of an organic nitrogen base, is first reacted with a compound of the formula III R-SO2Hal wherein R represents an optionally substituted alkyl, aryl or aralkyl radical and Hal represents a halogen atom, in an organic solvent and, if appropriate, in the presence of a base, (b) a compound of the formula I (TACS) in which A has the above meaning, is reacted with a silylating agent in an organic solvent and, if appropriate, in the presence of a base, and (c) the two products formed in (a) and (b) are reacted in their reaction solutions, and any protective group R1 present in the end product of the formula I is eliminated.
Patent IE-69265-B1 (IE)
Title: Chimaeric hepadnavirus core antigen proteins
Inventor: BROWN ALAN LOUIS
IPC: C07K19/00
Filed: 1990-09-18
Abstract: Particles, useful as a delivery system for an epitope, are composed of a chimaeric hepadnavirus core antigen protein wherein a foreign amino acid sequence comprising an epitope is inserted in or replaces all or part of the sequence of amino acid residues from 68 to 90 in the case where the core antigen is hepatitis B core antigen or the corresponding amino acid sequence in the case of the core antigen of another hepadnavirus.
Patent IE-63063-B1 (IE)
Title: Antagonist to interleukin-5 for preventing or reducing eosinophilia
Inventor: COFFMAN ROBERT L
IPC: A61P7/00
Filed: 1989-11-02
Abstract: A method of preventing or reducing eosinophilia associated with certain immune disorders is provided. The method comprises administering an effective amount of an antagonist to human interleukin-5. Preferably, the antagonist is a blocking monoclonal antibody specific for human interleukin-5, or a fragment or binding composition derived therefrom.
Patent IE-62825-B1 (IE)
Title: Analogs of botanic seed
Inventor: CARLSON WILLIAM C
IPC: A01H4/00
Filed: 1991-10-29
Abstract: A manufactured seed is disclosed which comprises a plant embryo preferably encapsulated, or at least in contact with, a hydrated oxygenated gel. The gel can be oxygenated by passing oxygen gas through a gel solution before curing the gel or by exposing the gel to oxygen gas after curing. The gel is preferably oxygenated by adding to an uncured gel solution a suitably stabilized emulsion of a perfluorocarbon compound or a silicone oil, which compounds are capable of absorbing large amounts of oxygen, and are non-toxic and inert. The seed analog can further comprise an outer shell at least partially surrounding the gel and embryo, thereby forming a capsule. The outer shell preferably is shaped to aid the radical of a germinating embryo in protrusively rupturing the capsule, thereby facilitating successful germination and minimizing incidence of seedling malformation. Other shell materials are selected to provide requisite rigidity to the capsule while imparting minimal restriction to successful germination. In a preferred embodiment for germinating embryos having cotyledon(s), at least the cotyledons are enclosed in a porous material resistant to penetration by the growing cotyledon(s), and the embryo and porous enclosure are encapsulated in a hydrated gel.
Patent LU-500639-B1 (LU)
Title: Method for screening endophytic bacteria resistant to garlic root-knot nematodes
Inventor: SHI QIANQIAN
IPC: C12N1/20
Filed: 2021-09-09
Granted: 2022-03-09
Abstract: Disclosed is a method for screening endophytic bacteria resistant to garlic root-knot nematodes, which belongs to the technical field of microorganisms. The method of the present invention includes separating single colonies with different morphologies from garlic root hair damaged by root-knot nematodes and purifying same; inoculating obtained single colonies into a lysogeny broth (LB) liquid culture medium for fermentation, to obtain fermentation supernatants; inoculating live root-knot nematodes into the fermentation supernatants; counting the number of dead nematodes after 24 h; calculating corrected death rates of the nematodes; and screening strains corresponding to a supernatant with a corrected death rate over 70%, to serve as screened endophytic bacteria resistant to the garlic root-knot nematodes. The method of the present invention is simple and high in efficiency and can screen biological control bacteria with a desirable direct contact killing effect on Meloidogyne incognita and provide a biological control resource for biological control of the root-knot nematodes.
Patent NO-302729-B1 (NO)
Inventor: MAKRIS PERRY
IPC: H04L12/56
Filed: 1989-11-30
Abstract: A packet switch receives data and processes it for assembly into packages. A bus allows communication between each of the data processing units of the switch and one or more storage units for storing the data packets. Arbitration for deciding which of the processing units will be granted access to the bus is performed by a system which selectively and alterably designates any of at least two different levels of priority of access to the bus for each of the processing units, and the relative percentages of time of access for the different priorty levels. The system assures greater access to the bus by those of the processing units having the higher level of priority. If communication is provided by two buses, the requests for access are alternated between them. The arbitration system provides selective access to the bus in any of a plurality of bus cycles including a read cycle, a write cycle and a read/modify/write cycle, and grants a request for access from a higher priority processing unit within one bus cycle.
Patent NO-308587-B1 (NO)
Inventor: HOCK JOHANN
IPC: A61K35/14
Filed: 1993-01-28
Abstract: Fibrinogen soln. which can be stored for at least 4 weeks at 18-25 deg. C is prepd. by treating the fibrinogen soln. at least twice with an absorbent, and collecting the liq. Pref. the soln. is made from a cryoprecipitate and contains 1.5-15 (5-11)% coagulable plasma protein. Absorbent is pref. an alkaline earth salt which is sparingly soluble, or is Al(OH)3, used in a concn. of up to 2.5 (0.05-0.5)% (w/v); or an anion exchange resin.
Patent NO-311952-B1 (NO)
Inventor: IMGRAM FRIEDRICH
IPC: B29L23/00
Filed: 1994-02-25
Abstract: A pipe end (13) of a pipe (12) consisting of polyolefin is deformed cold, that is to say at ambient temperature, with the aid of an expanding mandrel. Once the expanding mandrel has been withdrawn, the expanded pipe end (13) and a respectively desired connecting part, or the pipe end (11) of a further pipe (10), are plugged onto one another. The pipe end (13) consisting of polyolefin experiences only a reversible deformation and, as a result of it deforming back to its original shape, forms a firm, gas-tight connection to the connecting part or to the other pipe end (11). <IMAGE>
Patent NO-305936-B1 (NO)
Inventor: TORSTENSSON MIKAEL
IPC: B65D5/24
Filed: 1994-06-08
Abstract: The present invention is for a liquid tight sealed packaging which is obtained by folding of a flat sheet. One side of the sheet has a barrier material which is impermeable for the liquid product, for which the packaging is intended. The packaging can easily be opened and with satisfying result be closed again. The packaging is also cheap to produce and empty packagings take up little space. The packaging comprises a bottom 1 surrounded by short sides 2, 3 and long sides 4, 5. The sides are joined by corner parts which by a folding line 14 are separated in two parts 12 and 13. At each longer side 4, 5 there is a lid part 6, 10 the size of which is essentially the same as that of the bottom 1. One lid part 6 is intended to be a lower lid and is separated by a perforation 9 into an inner part 7 and a surrounding border 8. On each short side 2, 3 there is a flap 15, which also comprises and edge 18 delimited to the shorter side and the outer part of the flap by two folding lines 16, 17. <IMAGE>
Patent NO-313038-B1 (NO)
Inventor: BOTTE LUC
IPC: C25B9/00
Filed: 1996-02-02
Abstract: End section for an electrodialysis machine comprises a vertical plate (8) and frame (9) forming a cavity between them containing an electrode and connected to an inlet pipe (23,26) and an outlet pipe (22,24) for the electrolyte. The electrode is a vertical perforated metal sheet (12) positioned to form a chamber (21) between the plate, the sheet and the frame. This chamber is divided into vertical channels (27,28) by vertical partitions (29) and the inlet and outlet pipes open into this chamber. Electrodialysis machine containing a succession of vertical frames and membranes selectively permeable to ions, between two end sections is also claimed.
Patent NO-315686-B1 (NO)
Inventor: WATTS PETER
IPC: A61K9/48
Filed: 1996-12-18
Abstract: A colonic drug delivery composition is provided and comprises a starch capsule containing a drug, the starch capsule being provided with a coating such that the drug will only be released from the capsule in the colon. The coating may be a pH sensitive material, a redox sensitive material, or a material broken down by specific enzymes or bacteria present in the colon. The drug to be delivered may be one for local action in the colon or a systemically active drug to be absorbed from the colon.
Patent AT-506463-B1 (AT)
Title: Packung bestehend aus einem behälter und einem deckel
Inventor: REITERER FRANZ ING
IPC: B65D77/20
Filed: 2008-02-18
Granted: 2010-07-15
Abstract: Die Erfindung betrifft eine Packung 1a, 1c bestehend aus einem Behälter 2, 2a, dessen Wand 6, 6a zumindest im Bereich des Behälterrandes 4, 4a eine zum Behälterinneren hin ausgeformte Vertiefung 7, 7a aufweist, und einem Deckel 3a, 3c mit Grifflasche 11, 11a, wobei der Deckel 3a, 3c am Behälterrand 4, 4a über eine Siegelschicht befestigt ist.
Patent AT-508915-B1 (AT)
Title: Vorrichtung zum entfernen von haaren
IPC: A45D26/00
Filed: 2010-02-25
Granted: 2011-05-15
Abstract: Vorrichtung zum Entfernen von Haaren mit einem verdrillten Bereich (V) eines aufgespannten Bandes (1), wobei vom verdrillten Bereich (V) vier Bandabschnitte (1a, 1b, 1c, 1d) wegführen und zumindest zwei Bandabschnitte (1a, 1b) an zueinander beabstandeten Anliegepunkten (AP1, AP2) eines gemeinsamen Betätigungselements 2 anliegen, wobei sich durch Betätigen des Betätigungselements 2 der Abstand A der Anliegepunkte (AP1, AP2) der zumindest zwei Bandabschnitte (1a) ändert und dadurch der verdrillte Bereich (V) entlang des aufgespannten Bandes (1) wandert, wobei die Anliegepunkte (AP1, AP2) des Bandes 1 auf einem ovalen, vorzugsweise ellipsenförmigen Anliegebereich (OV) des Betätigungselements (2) liegen und sich durch Drehen des Betätigungselements (2) der Abstand (A) zwischen den Anliegepunkten (AP1, AP2) der Bandabschnitte (1a, 1b) ändert.
Patent AT-501955-B1 (AT)
Inventor: HARTNER FRANZ
IPC: C12N15/67
Filed: 2005-02-23
Granted: 2007-08-15
Abstract: Summary:  A mutant Pichia pastoris alcohol oxidase 1 (AOX1) promoter of the wild type Pichia pastoris AOX1 promoter (SEQ ID No. 1) comprising at least one mutation selected from the group consisting of: 
a) a transcription factor binding site (TFBS), 
b) nucleotides 170 to 235 (-784 to -719), nucleotides 170 to 191 (-784 to -763), nucleotides 192 to 213 (-762 to -741), nucleotides 192 to 210 (-762 to -744), nucleotides 207 to 209 (-747 to -745), nucleotides 214 to 235 (-740 to -719), nucleotides 304 to 350 (-650 to -604), nucleotides 364 to 393 (-590 to - 561), nucleotides 434 to 508 (-520 to -446), nucleotides 509 to 551 (-445 to -403), nucleotides 552 to 560 (-402 to -394), nucleotides 585 to 617 (-369 to -337), nucleotides 621 to 660 (-333 to -294), nucleotides 625 to 683 (-329 to -271), nucleotides 736 to 741 (-218 to -213), nucleotides 737 to 738 (-217 to - 216), nucleotides 726 to 755 (-228 to -199), nucleotides 784 to 800 (-170 to -154) or nucleotides 823 to 861 (-131 to -93) of Seq ID No. 1, and combinations thereof.
Patent AT-513151-B1 (AT)
Title: Verbrennungskraftmaschine mit Drehzahlregler
Inventor: POXHOFER MARKUS ING
IPC: F01L1/04
Filed: 2013-04-23
Granted: 2014-02-15
Abstract: Verbrennungskraftmaschine mit einer Kurbelwelle (6) und einer Nockenwelle (7), wobei an einer Seite der Kurbelwelle (6) ein treibendes Zahnrad (15) und an derselben Seite der Nockenwelle (7) ein getriebenes Zahnrad (17) angeordnet ist. Um einen einfachen und zuverlässigen Fliehkraftregler zu schaffen, der minimalen Bauraum beansprucht und bezüglich des Stellorgans möglichst günstig angeordnet ist, ist die Nockenwelle (7) über ihre ganze Länge hohl und am getriebenen Zahnrad (17) sind Fliehgewichte (30), die auf eine die Nockenwelle (7) durchsetzende Stange (31) wirken, und ist das Ende der Stange (31) am anderen Ende der Nockenwelle (7) mit einem Regel- beziehungsweise Stellorgan (37), insbesondere einer Einspritzpumpe (5) wirkverbunden.